Statistics from Altmetric.com
Since I became editor in late 2019, JIM has shown extraordinary growth across the board. I would like to take this opportunity to provide readers with a snapshot of JIM’s progress in 2020.
After a 3-year period of relatively little growth, submissions were up 78% in 2020 (figure 1), reaching an all-time high since transitioning to BMJ in 2016. Original research articles, reviews, and brief reports all increased by almost 70%. This growth is also reflected in an increase of published papers of approximately 40%, the result of the Editorial team’s continued focus on quality while also maintaining a stable acceptance rate of 30%.
Over the past several years, JIM has benefited from a push for open access. 2020 was no …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.